2009
DOI: 10.1152/ajplung.90436.2008
|View full text |Cite
|
Sign up to set email alerts
|

Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung

Abstract: Human cytochrome P-450 epoxygenase enzymes metabolize eicosapentaenoic acid (EPA), an omega-3-polyunsaturated fatty acid (PUFA), and leads to the production of 17(18)-epoxyeicosatetraenoic acid, or 17(18)-EpETE. The aim of the present study was to delineate the mode of action of 17(18)-EpETE on human pulmonary artery (HPA) and distal bronchi. Isometric tension measurements demonstrated that 17(18)-EpETE induced concentration-dependent relaxing effects in pulmonary artery and airway smooth muscles. Iberiotoxin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
61
1

Year Published

2010
2010
2018
2018

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 75 publications
(64 citation statements)
references
References 38 publications
2
61
1
Order By: Relevance
“…However, RBCs and plasma lipids also showed minor reductions in MUFA and PUFA pools. In a similar study of men on a Mediterranean diet fed 4 g/day n3-HUFA ethyl esters for 2 months, the magnitude of HUFA changes were similar to those observed in the current study; however, changes of platelet aggregation ( 44 ), and pulmonary smooth muscle relaxants ( 45 ). Although the literature pertaining to the production and function of n3 epoxides is limited, the similarity of their effects to the well-described AA-derived epoxides (46)(47)(48) suggest that future research focusing on the relative potency of these n3 and n6 metabolites is needed to fully appreciate the potential impact and mechanisms of P-OM3 treatments and the association to infl ammation and CVD risk in the population.…”
Section: P-om3 Impact On Cell and Plasma Fassupporting
confidence: 84%
“…However, RBCs and plasma lipids also showed minor reductions in MUFA and PUFA pools. In a similar study of men on a Mediterranean diet fed 4 g/day n3-HUFA ethyl esters for 2 months, the magnitude of HUFA changes were similar to those observed in the current study; however, changes of platelet aggregation ( 44 ), and pulmonary smooth muscle relaxants ( 45 ). Although the literature pertaining to the production and function of n3 epoxides is limited, the similarity of their effects to the well-described AA-derived epoxides (46)(47)(48) suggest that future research focusing on the relative potency of these n3 and n6 metabolites is needed to fully appreciate the potential impact and mechanisms of P-OM3 treatments and the association to infl ammation and CVD risk in the population.…”
Section: P-om3 Impact On Cell and Plasma Fassupporting
confidence: 84%
“…17,18-EEQ shares and, in several vascular beds, even largely exceeds the vasodilatory ( 57 ) and BK channel activating effects of EETs ( 58 ). Moreover, 17,18-EEQ relaxes airway smooth muscle cells in the human lung ( 59 ) and potently modulates the contractility of cardiomyocytes ( 37 ). Interestingly, a synthetic compound developed to mimic the effect of 17,18-EEQ on cardiomyocytes ( 21 ) was also effective when assayed in our C. elegans model.…”
Section: Discussionmentioning
confidence: 83%
“…CYP epoxygenases also convert the 3-PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to epoxy-derivatives ( 9 ), which are potent dilators of coronary arterioles ( 10-12 ) or pulmonary artery ( 13 ) and inhibit platelet aggregation ( 14 ). The EPA-derived epoxides account for fi ve epoxyeicosatetraenoic acids (5,8,11,14,and 17,, whereas the DHA-derived epoxides account for six epoxydocosapentaenoic acids (4,7,10,13,16,and 19,. A high regio-and stereoselectivity has been observed when testing the effects of chemically synthesized epoxides from AA and EPA.…”
mentioning
confidence: 99%